
Bayer says it plans to invest more than €500 million to establish additional manufacturing capacity for its haemophilia drugs at …
Facility investments from Amcor and Pluristem, Beanne Chemical falls foul of FDA inspectors, Novozymes acquisition plus a green chemistry app.

